Skip to content
StockMarketAgent
Healthcare / Medical - Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

AIM/VRCI stock hub

AIM/VRCI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

AIM/VRCIis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
7.2M
London Stock Exchange AIM
Market data

Live price

Current market quote for this ticker.

Current price
AIM/VRCI
In the news

Latest news · AIM/VRCI

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 16.9P75 23.5
Trailing P/En/a
P25 15.9P50 22.9P75 35.8
ROE-123.4
P25 -54.2P50 2.1P75 13.7
ROIC-73.7
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All AIM/VRCI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
170
Groups with data
11
Currency
USD
Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United Kingdom
Country code
UK
Employees
15
Employees Change
-3%
Employees Change Percent
-16.67
Enterprise value
GBX 7.1M
Exchange
London Stock Exchange AIM
Financial currency
USD
First seen
2026-05-10
Industry
Medical - Diagnostics & Research
Isin
GB00BM8HZD43
Last refreshed
2026-05-10
Market cap
GBX 7.2M
Price
GBX 0.46
Price currency
GBX
Rev Per Employee
93,086.6x
Sector
Healthcare
Sic
2835
Symbol
aim/VRCI
Website
https://vericidx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-77.33%
EV Earnings
-1.27x
EV/FCF
-1.52x
EV/Sales
5.05x
FCF yield
-64.64%
P/B ratio
3.97x
P/S ratio
5.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

13
MetricValue
Gross margin
81.6%
Gross Profit
GBX 1.1M
Gross Profit Growth
-53.25%
Gross Profit Growth Q
-53.25%
Gross Profit Growth3 Y
15.5%
Net Income
GBX -5.6M
Net Income Growth Years
2%
Pretax Margin
-398.12%
Profit Per Employee
GBX -370,595
ROA
-57.94
ROCE
-294.4
ROE
-123.4
ROIC
-73.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr1y
-72.02%
Cagr3y
-69.78%
Cagr5y
-63.21%
EPS Growth Years
2
Revenue Growth
-55.85x
Revenue Growth Q
-42.71x
Revenue Growth Years
1x
Revenue Growth3 Y
23.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
GBX 0.23
Assets
GBX 3.3M
Cash
GBX 340,863
Current Assets
GBX 1.3M
Current Liabilities
GBX 1.4M
Debt
GBX 205,832
Debt Equity
GBX 0.11
Debt FCF
GBX -0.04
Equity
GBX 1.8M
Interest Coverage
-428.8
Liabilities
GBX 1.5M
Long Term Assets
GBX 2M
Long Term Liabilities
GBX 95,237
Net Cash
GBX 135,032
Net Cash By Market Cap
GBX 1.88
Net Cash Growth
-97.18%
Net Debt Equity
GBX -0.07
Tangible Book Value
GBX 246,706
Tangible Book Value Per Share
GBX 0
WACC
11.24

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
0.91
Net Working Capital
GBX -364,220
Quick ratio
0.68
Working Capital
GBX -127,003
Working Capital Turnover
GBX 0.41

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-23.5%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-72%
200-day SMA
0.65
3Y total return
-97.24%
50-day SMA
0.53
50-day SMA vs 200-day SMA
50under200
5Y total return
-99.33%
All Time High
94.95
All Time High Change
-99.52%
All Time High Date
2021-02-08
All Time Low
0.43
All Time Low Change
7.06%
All Time Low Date
2026-04-28
ATR
0.06
Beta
1.3
Beta1y
0.04
Beta2y
-0.66
Ch YTD
-37.24
High
0.5
High52
1.75
High52 Date
2025-06-10
High52ch
-74%
Low
0.45
Low52
0.43
Low52 Date
2026-04-28
Low52ch
7.06%
Ma50ch
-13.73%
Price vs 200-day SMA
-29.49%
RSI
28.9
RSI Monthly
30.23
RSI Weekly
31.54
Sharpe ratio
-1.01x
Sortino ratio
-1.32
Total Return
-23.5%
Tr YTD
-37.24
Tr1m
-4.21%
Tr1w
-5.21%
Tr3m
-37.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
GBX -5.6M
Operating margin
-403.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
1,072,719,238%
Net Borrowing
-129,098.5
Shares Insiders
0.78%
Shares Institutions
68.94%
Shares Out
1,513,394,127
Shares Qo Q
-0.07%
Shares Yo Y
23.5%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

50
MetricValue
Adjusted FCF
GBX -4.7M
Average Volume
1,301,632.6x
Bv Per Share
0.01
CAPEX
GBX -2,190
Ch1m
-4.21
Ch1w
-5.21
Ch1y
-72
Ch3m
-37.24
Ch3y
-97.24
Ch5y
-99.33
Ch6m
-35
Change
-4.21%
Change From Open
-9
Close
0.48
Days Gap
5.26
Depreciation Amortization
449,644.1
Dollar Volume
1,288,969
Earnings Date
2026-06-02
EBIT
GBX -5.6M
EBITDA
GBX -5.2M
EPS
GBX -0.02
F Score
1
FCF
GBX -4.6M
FCF EV Yield
-65.87x
FCF Per Share
GBX -0
Financing CF
-141,601
Fiscal Year End
December
Founded
2,020
Investing CF
-3,650
Is Primary Listing
1
Last Earnings Date
2025-10-30
Last Report Date
2025-06-30
Ma150
0.67
Ma150ch
-32.2%
Ma20
0.5
Ma20ch
-8.08%
Net CF
-4,779,385
Next Earnings Date
2026-06-02
Open
0.5
Position In Range
10
Ppne
478,251.1
Price Date
2026-05-08
Ptbv Ratio
29.14
Relative Volume
2.31x
Revenue
1,396,299x
SBC By Revenue
6.85x
Share Based Comp
95,617
Tr6m
-35%
Volume
2,832,899
Z Score
-14.6
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does AIM/VRCI pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/VRCI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-72.0%
S&P 500 1Y: n/a
3Y total return
-97.2%
S&P 500 3Y: n/a
5Y total return
-99.3%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns AIM/VRCI?

Insider, institutional, and short-interest positioning.

Institutional ownership
+68.9%
Share of float held by funds and institutions
Insider ownership
+0.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+23.5%
Negative means the company is buying back shares.
Technical

AIM/VRCI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
28.9
Below 30: short-term oversold
Price vs 200-day MA
-29.5%
50/200-day relationship not available
Beta (5Y)
1.30
More volatile than the market
Sharpe ratio
-1.01
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About AIM/VRCI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/VRCI stock rating?

aim/VRCI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/VRCI analysis?

The full report lives at /stocks/aim/VRCI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/VRCI?

The latest report frames aim/VRCI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/VRCI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.